Volume 32, Issue 6 (9-2024)
JSSU 2024, 32(6): 7894-7911 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Pouladvand N, Azarnia M, Zeinali H, Fathi R, Tavana S. A Review of the Types of Chemotherapy Drugs Used to Induce Premature Ovarian Failure in Mice. JSSU 2024; 32 (6) :7894-7911
URL: http://jssu.ssu.ac.ir/article-1-6165-en.html
URL: http://jssu.ssu.ac.ir/article-1-6165-en.html
Abstract: (384 Views)
Introduction: The most common complication of chemotherapy is infertility due to premature ovarian failure (POF). POF is defined as the loss of normal ovarian function before age 40, characterized by increased gonadotropin levels, decreased estradiol levels, and diminished ovarian reserve, often leading to infertility. Despite the high impact of POF on general health and quality of life, the pathophysiology of this disease is unclear. For this purpose, animal models provide us with the opportunity to hypothetically investigate the pathogenesis of the disease comprehensively. The most common method of creating an animal model of premature ovarian failure is the use of chemotherapy drugs. In this study, the types of chemotherapy drugs and the relevant molecular pathways that play a role in creating the premature ovarian failure model in mice will be investigated
Conclusion: According to the studies, cyclophosphamide drug is introduced as the most common gonadotoxic drug in order to induce POF model in mice.
Conclusion: According to the studies, cyclophosphamide drug is introduced as the most common gonadotoxic drug in order to induce POF model in mice.
Type of Study: Review article |
Subject:
Biology
Received: 2024/01/18 | Accepted: 2024/03/17 | Published: 2024/09/5
Received: 2024/01/18 | Accepted: 2024/03/17 | Published: 2024/09/5
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
